Keywords: BRAF; follicular variant of papillary thyroid carcinoma; hürthle cell carcinoma; noninvasive follicular thyroid neoplasm with papillary-like nuclear features; RAS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Melanoma; Biomarker; ctDNA; BRAF; Immunotherapy;
Keywords: AMPK-GLUT1; AMP-activated protein kinase-glucose transporter 1; Bax; bcl-2 associated X protein; Bcl-2; B-cell lymphoma gene 2; Bim; bcl-2-like 4; BRAF; v-raf murine sarcoma viral oncogene homolog B1; Cdk; cyclin-dependent kinase; CIMP; CpG island methyla
Keywords: Colorectal cancer; Clinical trials; KRAS; BRAF; Her2; Immunotherapy;
Keywords: BRAF; Genomic profiling; KRAS; Mutation; Right colon cancer;
Keywords: Colorectal cancer; Liquid biopsy; KRAS; NRAS; BRAF;
Keywords: ABCB1; ATP-binding cassette sub-family B member 1; ABCG; ATP-binding cassette drug efflux transporters; ACD; autophagic cell death; AKT; alpha serine/threonine protein kinase; ALDH; aldehyde dehydrogenase; AMPK; AMP-activated protein kinase; AP; apurinic/
Keywords: Colorectal carcinoma; Serrated polyp pathway; KRAS; BRAF; CpG island methylator phenotype;
Keywords: 1,2,4-Triazole; Antiproliferative; EGFR; BRAF; Tubulin and molecular docking;
Keywords: ACVR1; Activin A receptor type1; ATRX; A-thalassemia/mental retardation syndrome X-linked; BMP; Bone morphogenetic protein; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CNS; Central nervous system; DAXX; Death domain-associated protein; DNMT; DNA
Keywords: Kinase inhibitors; Selectivity; Ring closure; Rigidification; Abl; BRAF;
Keywords: Melanoma; Metastasis; Brain; BRAF; Immunotherapy;
Keywords: Melanoma; CDDP; Starvation; BRAF; Apoptosis;
Keywords: Melanoma; Driver mutation; Primary; Metastasis; Mutational heterogeneity; BRAF;
Keywords: AMG; Aminoguanidine; APE/Ref-1; Apurinic/apyrimidinic endonuclease-1/redox factor-1; ARG1; Arginine 1; BCL2; B-cell lymphoma 2 gene; BRAF; B- Rapidly Accelerated Fibrosarcoma; cGMP; Cyclic guanosine monophosphate; cNOS; constitutional nitric oxide synthas
Keywords: ASXL1; additional sex combs like 1; BCOR; BCL6 corepressor; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CEBPA; CCAAT/enhancer binding protein alpha; DNMT3A; DNA methyltransferase 3A; FLT3; fms-like tyrosine kinase; IDH1/2; isocitrate dehydrogenas
Keywords: Systems Biology; Cancer Therapy; Targeted Therapy; BRCA; BRAF; Optimized Therapy; Modeling; Signaling Dynamics;
Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities
Keywords: Diphenylthiazole; Anticancer; Anti-inflammatory; COX-2; BRAF; EGFR;
Keywords: immune therapy; metastatic melanoma; targeted therapy; APC; antigen presenting cells; BRAF; v-RAF murine sarcoma viral oncogene; CRR; complete response rate; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; irAEs; immune related adverse events; KA;
Keywords: ARAF; BRAF; Erdheim-Chester disease; Langerhans cell histiocytosis; MAP kinase; MEK;
Keywords: NSCLC; ROS1; RET; NTRK; MET; BRAF; KRAS; Driver mutations;
Keywords: Diallyl sulfide; Mitotic arrest; Cell death; Autophagic flux; Zebrafish xenografts; Baf; bafilomycin A1; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CFAs; colony formation assays; CHCA; α-cyano-4-hydroxy-cinnamic acid; CHX; cycloheximide; CIMP;
Keywords: Papillary thyroid carcinoma; Occult primary thyroid carcinoma; Lymph node metastasis; BRAF; Poorly differentiated thyroid carcinoma; Anaplastic thyroid carcinoma;
Keywords: BRAF; NRAS; MEK; Kinase inhibitors; Targeted therapy; Melanoma;
Keywords: Lung sarcomatoid; Genomic profiling; Tumor mutational burden; BRAF; MET exon 14; Immunotherapy;
Keywords: 3-MA; 3-methyladenine; Asc; ascorbate; ATM; ataxia telangiectasia mutated; ATP; adenosine triphosphate; BRAF; murine sarcoma viral oncogene homolog B; Cat; catalase; Chk2; checkpoint kinase 2; CQ; chloroquine; Cys-SO3H; cysteine S-sulfate; DHA; dehydroasc
Keywords: Epidermal growth factor receptor (EGFR); BRAF; Focal adhesion kinase (FAK); Tubulin polymerization; Cancer cell lines; MDR; multidrug resistance; EGFR; epidermal growth factor receptor; EMEA; European Medicines Evaluation Agency; FDA; US Food and Drug Adm
Keywords: Early onset colorectal cancer; MSI; BRAF;
Keywords: CRC; colorectal cancer; SNP; single nucleotide polymorphism; CNV; copy number variant; GWAS; genome-wide association studies; GO; gene ontology; BP; biological process; CAM; cell adhesion molecule; CIN; chromosomal instability; MSI; microsatellite instabi
Keywords: LS; Lynch syndrome; CRC; colorectal cancer; HNPCC; hereditary non-polyposis colon cancer; MMR; mismatch repair; FAP; familial adenomatous polyposis; CFS; cancer family syndrome; MSI; microsatellite instability; IDL; insertion/deletion loop; MSH2; human mu
Keywords: BRAF; diagnosis; immune blockade; immunochemistry; melanoma; pathology; PD-1; PD-L1; targeted therapy; therapy; TILs; treatment
Keywords: Melanoma; BRAF; EMT; Lung cancer; EGFR;
Keywords: Histiocyte; Langerhans cell; Macrophage; Cigarette smoking; Lung; Interstitial; BRAF;
Keywords: Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: Melanoma; Liquid biopsy; Circulating tumor cells; Cell-free circulating tumor DNA; Cell-free DNA; Cell-free microRNA; Ab; antibody; AIM1; absent in melanoma-1; AJCC; American Joint Committee on Cancer; BRAF; B-Raf proto-oncogene, serine/threonine kinase;
Keywords: Biomarkers; BAP1; BRAF; classification; diagnosis; genetics; genomics; melanocytic tumours; melanoma; molecular biology; pathology; precision oncology; RAS; Spitz tumours; spitzoid neoplasms; targeted therapy
Keywords: NIFT-P; follicular variant; papillary thyroid carcinoma; non-invasive; cytology; BRAF;
Keywords: Predictive Markers; Prognostic Markers; Colorectal Cancer; Molecular Subtypes; RAS; BRAF; MSI; DNA Mismatch Repair; Immunotherapy; Targeted Therapy; Biologics; Anti-EGFR; Anti-VEGF; CCS; colon cancer subtypes; CIMP; CpG island methylator phenotype; CIN; c
Keywords: Melanoma; MAPK; WNT; PI3K; BRAF; EMT;
Keywords: Melanoma; Vagina; Metástasis; MelanA; BRAFMelanoma; Vagina; Metastasis; MelanA; BRAF
Keywords: Serrated polyp; Traditional serrated adenoma; CIMP; KRAS; BRAF
Keywords: 3-AP; 3-aminopyridine-2-carboxaldehyde thiosemicarbazone; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and Rad3-related protein; AMP/ADP/ATP; adenosine mono-, di-, and tri-phosphate; BLM; Bloom syndrome RecQ helicase-like; BRAF; V-raf mu
Keywords: melanoma; BRAF; oncogene; metabolism; mitochondria
Keywords: TERT; Outcome; BRAF; RAS; Genomics; Epidemiology
Keywords: BRAF; v-raf murine sarcoma viral oncogene homolog; MEK; MAP kinase-ERK kinase; KIT; V-KIT Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; PD-1/PD-L1; programmed death-1/ programmed death-1 li
Keywords: GIST; KIT; PDGFRA; Succinate dehydrogenase; BRAF
Keywords: Glioma; Astrocytoma; Oligodendroglioma; Glioblastoma; Biomarker; IDH; ATRX; TP53; TERT; EGFR; H3F3A; BRAF; 1p/19q
Keywords: Anti-cancer therapies; Cancer attractors; Cancer stem cells; Hypoxia; Inflammation; Interactome; Metabolic modeling; Networks; Senescence; Signaling; AKT; RAC-alpha serine/threonine protein kinase; BMI1; polycomb ring finger oncogene; C/EBP; CCAAT/enhance
Keywords: Diffuse sclerosing variant; Thyroid; Papillary carcinoma; BRAF; Molecular biology; Review;
Keywords: Langerhans cell histiocytosis; LCH; BRAF; MAP2K1; MEK1;